Search Within

Gary Schwartz

  1. "Body Imaging Service"
Formats
  1. Journal Article (18)
  2. Meeting Abstract (15)
Groups
  1. Body Imaging Service (33)
  2. Radiology, Department of (33)
  3. Department of Medicine (32)
  4. Solid Tumor Oncology Division (32)
  5. Biostatistics Service (23)
  6. Epidemiology and Biostatistics (23)

More Groups

People
  1. Richard Carvajal (18)
  2. Manish Shah (13)
  3. Mark Dickson (13)
  4. Robert Lefkowitz (12)
  5. David Kelsen (11)
  6. Archie Tse (9)

More People

Years
  1. 2014 (3)
  2. 2013 (6)
  3. 2012 (3)
  4. 2011 (3)
  5. 2010 (1)
  6. 2009 (4)

More Years

Publications
  1. Journal of Clinical Oncology (18)
  2. Clinical Cancer Research (4)
  3. Cancer Chemotherapy and Pharmacology (2)
  4. JAMA - Journal of the American Medical Association (2)
  5. Annals of Oncology (1)
  6. Blood (1)

More Publications

Publishers
  1. American Society of Clinical Oncology (18)
  2. American Association for Cancer Research (4)
  3. Springer (3)
  4. American Medical Association (2)
  5. Oxford University Press (2)
  6. American Society of Hematology (1)

More Publishers

Results (33)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A phase II study of docetaxel (D) followed by flavopiridol (F) in advanced, gemcitabine-refractory pancreatic cancer (PC)
    Meeting Abstract

    Carvajal, R. D.; Shah, M. A.; Tse, A.; Lefkowitz, R.; Kelsen, D. P.; Schwartz, G. K.; O'Reilly, E. M.
    Journal of Clinical Oncology (2008)

    Fulltext@MSK | Save
  • A phase 1 dose-escalation study of irinotecan in combination with 17-allylamino-17-demethoxygeldanamycin in patients with solid tumors
    Journal Article

    Tse, A. N.; Klimstra, D. S.; Gonen, M.; Shah, M.; Sheikh, T.; Sikorski, R.; Carvajal, R.; Mui, J.; Tipian, C.; O'reilly, E.; more...
    Clinical Cancer Research (2008)

    Fulltext@MSK | Save
  • Phase II trial of sequential paclitaxel and 1 h infusion of bryostatin-1 in patients with advanced esophageal cancer
    Journal Article

    Ku, G. Y.; Ilson, D. H.; Schwartz, L. H.; Capanu, M.; O'reilly, E.; Shah, M. A.; Kelsen, D. P.; Schwartz, G. K.
    Cancer Chemotherapy and Pharmacology (2008)

    Fulltext@MSK | Save
  • Pharmacokinetics (PK) of split-dose flavopiridol (F) administered with CPT-11 (CPT) and cisplatin (Cis)
    Meeting Abstract

    Carvajal, R. D.; Tse, A.; Wu, N.; Gonen, M.; Lefkowitz, R.; Dials, H.; Barbi, A.; Mui, J.; Schwartz, G. K.; Shah, M.
    Journal of Clinical Oncology (2007)

    Fulltext@MSK | Save
  • Phase I dose-finding study of weekly docetaxel followed by flavopiridol for patients with advanced solid tumors
    Journal Article

    Fornier, M. N.; Rathkopf, D.; Shah, M.; Patil, S.; O'reilly, E.; Tse, A. N.; Hudis, C.; Lefkowitz, R.; Kelsen, D. P.; Schwartz, G. K.
    Clinical Cancer Research (2007)

    Fulltext@MSK | Save
  • Multicenter phase II study of irinotecan, cisplatin, and bevacizumab in patients with metastatic gastric or gastroesophageal junction adenocarcinorna
    Journal Article

    Shah, M. A.; Ramanathan, R. K.; Ilson, D. H.; Levnor, A.; D'adamo, D.; O'reilly, E.; Tse, A.; Trocola, R.; Schwartz, L.; Capanu, M.; more...
    Journal of Clinical Oncology (2006)

    Fulltext@MSK | Save
  • Measuring tumor response and shape change on CT: Esophageal cancer as a paradigm
    Journal Article

    Schwartz, L. H.; Colville, J. A. C.; Ginsberg, M. S.; Wang, L.; Mazumdar, M.; Kalaigian, J.; Hricak, H.; Ilson, D.; Schwartz, G. K.
    Annals of Oncology (2006)

    Fulltext@MSK | Save
  • A multicenter phase II study of irinotecan (CPT), cisplatin (CIS), and bevacizumab (BEV) in patients with unresectable or metastatic gastric or gastroesophageal junction (GEJ) adenocarcinoma
    Meeting Abstract

    Shah, M. A.; Ilson, D.; Ramanathan, R. K.; Levner, A.; D'adamo, D.; Schwartz, L.; Casper, E.; Schwartz, G. K.; Kelsen, D. P.
    Journal of Clinical Oncology (2005)

    Fulltext@MSK | Save
  • A phase I clinical trial of the sequential combination of irinotecan followed by flavopiridol
    Journal Article

    Shah, M. A.; Kortmansky, J.; Motwani, M.; Drobnjak, M.; Gonen, M.; Yi, S.; Weyerbacher, A.; Cordon-Cardo, C.; Lefkowitz, R.; Brenner, B.; more...
    Clinical Cancer Research (2005)

    Fulltext@MSK | Save
  • Cetuximab shows activity in colorectal cancer patients with tumors that do not express the epidermal growth factor receptor by immunohistochemistry
    Journal Article

    Chung, K. Y.; Shia, J.; Kemeny, N. E.; Shah, M.; Schwartz, G. K.; Tse, A.; Hamilton, A.; Pan, D.; Schrag, D.; Schwartz, L.; more...
    Journal of Clinical Oncology (2005)

    Fulltext@MSK | Save